Home › Compare › LOBEF vs PLD

LOBEF vs PLD: Dividend Comparison 2026

LOBEF yields 3861.00% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LOBEF wins by $5102776617533.50M in total portfolio value
10 years
LOBEF
LOBEF
● Live price
3861.00%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5102776617540.00M
Annual income
$4,855,397,881,919,778,000.00
Full LOBEF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — LOBEF vs PLD

📍 LOBEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLOBEFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LOBEF + PLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LOBEF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LOBEF
Annual income on $10K today (after 15% tax)
$328,185.33/yr
After 10yr DRIP, annual income (after tax)
$4,127,088,199,631,811,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, LOBEF beats the other by $4,127,088,199,627,343,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LOBEF + PLD for your $10,000?

LOBEF: 50%PLD: 50%
100% PLD50/50100% LOBEF
Portfolio after 10yr
$2551388308773.25M
Annual income
$2,427,698,940,962,517,000.00/yr
Blended yield
95.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

LOBEF
No analyst data
Altman Z
-9.3
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LOBEF buys
0
PLD buys
0
No recent congressional trades found for LOBEF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLOBEFPLD
Forward yield3861.00% ✓3.18%
Annual dividend / share$2.00$4.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4% ✓
Portfolio after 10y$5102776617540.00M ✓$6.50M
Annual income after 10y$4,855,397,881,919,778,000.00 ✓$5,256,436.18
Total dividends collected$5085877075297.57M ✓$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: LOBEF vs PLD ($10,000, DRIP)

YearLOBEF PortfolioLOBEF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$396,800$386,100.39$11,255$555.24+$385.5K → LOBEF
2$14,742,780$14,318,203.95$13,062$1,018.59+$14.73M → LOBEF
3$512,952,973$497,178,198.17$15,903$1,926.67+$512.94M → LOBEF
4$16,715,748,598$16,166,888,916.48$20,839$3,823.32+$16715.73M → LOBEF
5$510,255,139,456$492,369,288,456.53$30,464$8,166.08+$510255.11M → LOBEF
6$14,592,492,784,652$14,046,519,785,434.00$52,054$19,457.30+$14592492.73M → LOBEF
7$391,042,310,644,499$375,428,343,364,921.60$109,886$54,188.93+$391042310.53M → LOBEF
8$9,820,789,713,309,148$9,402,374,440,919,534.00$304,030$186,451.18+$9820789713.01M → LOBEF
9$231,195,080,018,900,830$220,686,835,025,660,030.00$1,166,125$840,813.32+$231195080017.73M → LOBEF
10$5,102,776,617,540,002,000$4,855,397,881,919,778,000.00$6,504,190$5,256,436.18+$5102776617533.50M → LOBEF

LOBEF vs PLD: Complete Analysis 2026

LOBEF — Stock

Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. It develops psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder, as well as devices for the efficient application of medications. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.

Full LOBEF Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this LOBEF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LOBEF vs SCHDLOBEF vs JEPILOBEF vs OLOBEF vs KOLOBEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.